UY31105A1 - Predicción pronóstica del melanoma - Google Patents
Predicción pronóstica del melanomaInfo
- Publication number
- UY31105A1 UY31105A1 UY31105A UY31105A UY31105A1 UY 31105 A1 UY31105 A1 UY 31105A1 UY 31105 A UY31105 A UY 31105A UY 31105 A UY31105 A UY 31105A UY 31105 A1 UY31105 A1 UY 31105A1
- Authority
- UY
- Uruguay
- Prior art keywords
- markers
- cancer
- melanoma
- forecast
- prognostic
- Prior art date
Links
- 201000001441 melanoma Diseases 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 5
- 201000011510 cancer Diseases 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000004393 prognosis Methods 0.000 abstract 2
- 230000002068 genetic effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invención se refiere a marcadores pronóstico y distintivos pronósticos, así como a composiciones y a métodos para determinar el pronóstico del cáncer, en particular del melanoma, en un paciente. En particular, la invención se refiere al uso de marcadores proteínicos y genéticos para predecir el riesgo de progresión de un cáncer, como por ejemplo de un melanoma, sobre la base de marcadores y distintivos compuestos por marcadores. En diversos aspectos, la invención suministra métodos, composiciones, kits y sistemas a base de marcadores pronósticos del cáncer, en particular marcadores pronósticos del cáncer, en particular marcadores pronósticos de melanoma, para contribuir al pronóstico y tratamiento del cáncer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ555363A NZ555363A (en) | 2007-05-24 | 2007-05-24 | Prognosis prediction for melanoma cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY31105A1 true UY31105A1 (es) | 2009-01-05 |
Family
ID=40032133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY31105A UY31105A1 (es) | 2007-05-24 | 2008-05-26 | Predicción pronóstica del melanoma |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US8822149B2 (es) |
| EP (2) | EP3176270B1 (es) |
| JP (5) | JP5943315B2 (es) |
| CN (1) | CN101743327B (es) |
| AR (1) | AR066725A1 (es) |
| AU (1) | AU2008253836B2 (es) |
| CA (1) | CA2725602A1 (es) |
| CL (1) | CL2008001517A1 (es) |
| DK (2) | DK2158332T3 (es) |
| ES (2) | ES2622858T3 (es) |
| NZ (1) | NZ555363A (es) |
| PT (2) | PT2158332T (es) |
| SG (2) | SG10201912289SA (es) |
| TW (2) | TWI609967B (es) |
| UY (1) | UY31105A1 (es) |
| WO (1) | WO2008143533A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120135415A1 (en) * | 2002-11-15 | 2012-05-31 | Morehouse School Of Medicine | Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies |
| CN107102142A (zh) | 2007-03-27 | 2017-08-29 | 伊缪诺维亚公司 | 检测腺癌的蛋白标志/标记 |
| JP5683280B2 (ja) * | 2011-01-04 | 2015-03-11 | 株式会社日立製作所 | 診療支援システム |
| CN102617734B (zh) * | 2011-12-28 | 2013-09-04 | 暨南大学 | 抗FGF-2抗体Dab-2及其应用 |
| US9336302B1 (en) | 2012-07-20 | 2016-05-10 | Zuci Realty Llc | Insight and algorithmic clustering for automated synthesis |
| US9355105B2 (en) * | 2012-12-19 | 2016-05-31 | International Business Machines Corporation | Indexing of large scale patient set |
| ES2690584T3 (es) | 2013-03-14 | 2018-11-21 | Castle Biosciences Inc. | Métodos para predecir el riesgo de metástasis en melanoma cutáneo |
| WO2016177722A1 (en) * | 2015-05-05 | 2016-11-10 | Medizinische Universität Wien | Computerized device and method for processing image data |
| WO2018009887A1 (en) * | 2016-07-08 | 2018-01-11 | University Of Hawaii | Joint analysis of multiple high-dimensional data using sparse matrix approximations of rank-1 |
| US11205103B2 (en) | 2016-12-09 | 2021-12-21 | The Research Foundation for the State University | Semisupervised autoencoder for sentiment analysis |
| US10692605B2 (en) * | 2018-01-08 | 2020-06-23 | International Business Machines Corporation | Library screening for cancer probability |
| TW202018727A (zh) | 2018-11-09 | 2020-05-16 | 財團法人工業技術研究院 | 整體式學習預測方法與系統 |
| EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN112200391B (zh) * | 2020-11-17 | 2023-07-04 | 国网陕西省电力公司经济技术研究院 | 基于k-近邻互信息特征简化的配电网边缘侧负荷预测方法 |
| CN116179703B (zh) * | 2023-02-16 | 2024-11-15 | 厦门艾德生物医药科技股份有限公司 | 用于黑色素瘤预后的分子标记物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007008239A (es) | 2005-01-05 | 2007-08-17 | Abbott Lab | Inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo 1. |
| CA2614946A1 (en) * | 2005-01-07 | 2006-07-13 | The Johns Hopkins University | Biomarkers for melanoma |
| US7615349B2 (en) * | 2006-09-07 | 2009-11-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
| CA2664567C (en) * | 2006-10-04 | 2016-04-26 | Dana-Farber Cancer Institute, Inc. | Tumor immunity |
-
2007
- 2007-05-24 NZ NZ555363A patent/NZ555363A/en unknown
-
2008
- 2008-05-23 JP JP2010509293A patent/JP5943315B2/ja not_active Expired - Fee Related
- 2008-05-23 SG SG10201912289SA patent/SG10201912289SA/en unknown
- 2008-05-23 TW TW103127682A patent/TWI609967B/zh not_active IP Right Cessation
- 2008-05-23 CL CL2008001517A patent/CL2008001517A1/es unknown
- 2008-05-23 PT PT87669677T patent/PT2158332T/pt unknown
- 2008-05-23 CA CA2725602A patent/CA2725602A1/en not_active Abandoned
- 2008-05-23 SG SG10201509568QA patent/SG10201509568QA/en unknown
- 2008-05-23 WO PCT/NZ2008/000118 patent/WO2008143533A1/en not_active Ceased
- 2008-05-23 ES ES08766967.7T patent/ES2622858T3/es active Active
- 2008-05-23 CN CN2008800248635A patent/CN101743327B/zh not_active Expired - Fee Related
- 2008-05-23 TW TW097119301A patent/TWI582236B/zh not_active IP Right Cessation
- 2008-05-23 PT PT162033013T patent/PT3176270T/pt unknown
- 2008-05-23 DK DK08766967.7T patent/DK2158332T3/en active
- 2008-05-23 DK DK16203301.3T patent/DK3176270T3/da active
- 2008-05-23 ES ES16203301T patent/ES2821300T3/es active Active
- 2008-05-23 EP EP16203301.3A patent/EP3176270B1/en not_active Not-in-force
- 2008-05-23 AU AU2008253836A patent/AU2008253836B2/en not_active Ceased
- 2008-05-23 EP EP08766967.7A patent/EP2158332B1/en not_active Not-in-force
- 2008-05-26 UY UY31105A patent/UY31105A1/es active IP Right Grant
- 2008-05-26 AR ARP080102210A patent/AR066725A1/es active IP Right Grant
-
2009
- 2009-11-23 US US12/592,385 patent/US8822149B2/en active Active
-
2014
- 2014-08-29 US US14/472,755 patent/US9534258B2/en not_active Expired - Fee Related
- 2014-10-31 JP JP2014223331A patent/JP2015061528A/ja active Pending
-
2016
- 2016-12-14 JP JP2016242254A patent/JP6404304B2/ja not_active Expired - Fee Related
- 2016-12-27 US US15/391,293 patent/US10266902B2/en not_active Expired - Fee Related
-
2018
- 2018-09-12 JP JP2018170779A patent/JP2019004907A/ja active Pending
-
2020
- 2020-06-04 JP JP2020097666A patent/JP2020150949A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY31105A1 (es) | Predicción pronóstica del melanoma | |
| MX2009010439A (es) | Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. | |
| MX2011011641A (es) | Material para cojinete de deslizamiento. | |
| MX2017008421A (es) | Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga. | |
| DOP2013000036A (es) | Derivados de ciclobutano como inhibidores de jak | |
| CY1117833T1 (el) | Νεες συνθεσεις και μεθοδοι για την αγωγη του καρκινου | |
| CO7160023A2 (es) | Métodos y aparatos para predecir riesgo de cáncer de próstata y volumen de glándula prostática | |
| EA201171367A1 (ru) | Винилиндазолильные соединения | |
| MX2007014132A (es) | Compuestos de diarilhidantoina. | |
| MX2012013256A (es) | Composiciones y metodos para el tratamiento de leucemia. | |
| EA200971079A1 (ru) | ГЕНЕТИЧЕСКИЕ ВАРИАНТЫ В Chr5p12 И 10q26 В КАЧЕСТВЕ МАРКЕРОВ ДЛЯ ПРИМЕНЕНИЯ ПРИ ОЦЕНКЕ РИСКА, ДИАГНОСТИРОВАНИИ, ПРОГНОЗИРОВАНИИ И ЛЕЧЕНИИ РАКА ГРУДИ | |
| BRPI1013688A8 (pt) | Proteínas de ligação de il-17. | |
| MX386750B (es) | MARCADORES DE METILACIÓN Y DE miARN PARA LA DETECCIÓN DE CÁNCER. | |
| CL2009001263S1 (es) | Maquina de afeitar. | |
| MX2014011503A (es) | Metodos de pronostico, diagnostico y tratamiento de la fibrosis pulmonar idiopatica. | |
| MX2013008367A (es) | Firmas de esxpresion genetica de cancer de colon y metodos de uso. | |
| WO2012006589A3 (en) | Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling | |
| CL2008001682A1 (es) | Metodos para el mejoramiento de plantas mediante el uso de informacion directa de secuencias de acidos nucleicos. | |
| MX2015000008A (es) | Uso de marcadores en el diagnostico y tratamiento de cancer de prostata. | |
| BRPI0707040B8 (pt) | Método in vitro de seleção de um composto, método in vitro de previsão da presença de câncer, método de determinação in vitro da eficiência de um tratamento anticancerígeno e uso de um composto | |
| MX2015004610A (es) | Metodo para diagnostico, pronostico y tratamiento de metastasis de cancer de prostata usando c-maf. | |
| MX2011010425A (es) | Agentes terapeuticos para el tratamiento de enfermedades asociadas con una proliferacion celular indeseada. | |
| NI200700126A (es) | Metodos y sistemas para el pronostico y tratamiento de tumores solidos | |
| ATE532814T1 (de) | Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen | |
| CR9298A (es) | Marcadores farmacogenomicos para el pronostico de tumores solidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 110 | Patent granted |
Effective date: 20201022 |